Compound ID | 202
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Membrane-active agent. Additionally causes mislocalisation of FtsZ, PBP2, and PBP4; cell wall synthesis inhibitor |
| Target Pathogen: | Active against methicillin-resistant Staphylococcus aureus |
| Combined with other compounds: | Yes |
| Propensity to select resistant mutants: | Yes |
| Description: | Synthetic compound from ICCB-Longwood Screening Facility (New England Regional Centers of Excellence) small molecule collection; a quinolinol derivative; potentiates beta-lactams; shows no toxicity to mammalian cells |
| Institute where first reported: | Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA |
| Year first mentioned: | 2015 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/2820501 |
| Citations: |
|